Wednesday, June 10, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 21 of 1,261
  1. US 12385044

    Modified double-stranded RNA agents

    Alnylam Pharmaceuticals, Inc. Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  2. US 12383567

    Use of cannabinoids in the treatment of epilepsy

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  3. US 12383538

    Use of mTOR inhibitors for prevention of intestinal polyp growth and cancer

    The Board of Regents of the University of Texas System Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  4. US 12384743

    Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

    AXSOME MALTA LTD. Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  5. US 12383536

    CRF receptor antagonists and methods of use

    Neurocrine Biosciences, Inc. Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  6. US 12384845

    Activatable masked anti-CTLA4 binding proteins

    Xilio Development, Inc. Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  7. US 12384789

    Compounds for treating Huntington's disease

    PTC THERAPEUTICS, INC. Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  8. US 12384779

    Bicyclic compounds

    Aligos Therapeutics, Inc. Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  9. US 12384775

    Pyrimid-2-yl-pyrazole compounds as IRAK inhibitors

    Rigel Pharmaceuticals, Inc. Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  10. US 12384753

    17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  11. US 12384773

    Thiazole compounds and methods of use thereof

    Arcus Biosciences, Inc. Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  12. US 12383626

    Polyoxazoline-drug conjugates with novel pharmacokinetic properties

    Serina Therapeutics (AL), Inc. Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  13. US 12383629

    DNA-affibody-drug nanoparticles for inhibiting the metastasis of cancer cells overexpressing HER2

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  14. US 12383618

    Expression vector delivery system and use thereof for inducing an immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  15. US 12383566

    Inhibition of SLC transporter activity or expression to attenuate anthracycline-induced cardiotoxicity

    Northwestern University Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  16. US 12384797

    Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia

    PTC THERAPEUTICS, INC. Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  17. US 12385013

    Differentiation of pancreatic endocrine cells

    Vertex Pharmaceuticals Incorporated Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  18. US 12383733

    Iontophoresis-based patch type medicine absorption device

    ROOTONIX Co., Ltd. Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  19. US 12383500

    Nanoliposome compositions and methods of using the same

    United States Government as represented by the Department of Veterans Affairs Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  20. US 12383499

    Scale up synthesis of silicasome nanocarriers

    The Regents of the University of California Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  21. US 12384750

    Ras inhibitors

    Revolution Medicines, Inc. Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  22. US 12383652

    Nanofiber structures and methods of manufacture and use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  23. US 12383554

    Compositions and methods to protect mammalian tissue against cold and other metabolic stresses

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted
  24. US 12383655

    Methods of isolating and using descemet's membrane and compositions including isolated descemet's membrane

    Regents of the University of Minnesota Β· Granted Aug 12, 2025 Β· Expires Aug 7, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.